Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab-Reference-Cited by-同舟云学术

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

Published:2008 Issue:5 Volume:58 Page:1248-1257
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Mitoma Hiroki,Horiuchi Takahiko,Tsukamoto Hiroshi,Tamimoto Yasuhiro,Kimoto Yasutaka,Uchino Ayumi,To Kentaro,Harashima Shin-Ichi,Hatta Nobuaki,Harada Mine

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference40 articles.

1. Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?

2. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF

3. The Tumor Necrosis Factor Ligand and Receptor Families

Cited by 303 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors;2024-07-30

2. Biolayer interferometry and its applications in drug discovery and development;TrAC Trends in Analytical Chemistry;2024-07

3. Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseases;Rheumatology;2024-05-25

4. Genetic biomarkers for diagnosis and treatment of spondyloarthropathies in Moroccan population;Human Gene;2024-05

5. Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS);RMD Open;2024-03